G

GemPharmatech Co Ltd
SSE:688046

Watchlist Manager
GemPharmatech Co Ltd
SSE:688046
Watchlist
Price: 12.94 CNY -6.71% Market Closed
Market Cap: 5.3B CNY
Have any thoughts about
GemPharmatech Co Ltd?
Write Note

GemPharmatech Co Ltd
Short-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

GemPharmatech Co Ltd
Short-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
G
GemPharmatech Co Ltd
SSE:688046
Short-Term Investments
ÂĄ757.8m
CAGR 3-Years
N/A
CAGR 5-Years
91%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Short-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Short-Term Investments
ÂĄ418.1m
CAGR 3-Years
-18%
CAGR 5-Years
27%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Short-Term Investments
ÂĄ375.2m
CAGR 3-Years
-48%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Short-Term Investments
ÂĄ42.5m
CAGR 3-Years
-5%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
W
WuXi XDC Cayman Inc
HKEX:2268
Short-Term Investments
ÂĄ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

GemPharmatech Co Ltd
Glance View

Market Cap
5.3B CNY
Industry
Life Sciences Tools & Services

GemPharmatech Co., Ltd. engages in research and development, manufacture, and sale of experimental mouse models. The company is headquartered in Nanjing, Jiangsu and currently employs 1,342 full-time employees. The company went IPO on 2022-04-25. The firm uses gene-editing and other technologies to produce mouse models. The firm also involves in the business of customized model breeding, drug efficacy analysis, and model customization. The Company’s products are mainly used to satisfy the experimental demands in the fields of gene function cognition, disease mechanisms analysis, drug target discovery, and other fundamental researches.

Intrinsic Value
20.3 CNY
Undervaluation 36%
Intrinsic Value
Price
G

See Also

What is GemPharmatech Co Ltd's Short-Term Investments?
Short-Term Investments
757.8m CNY

Based on the financial report for Dec 31, 2023, GemPharmatech Co Ltd's Short-Term Investments amounts to 757.8m CNY.

What is GemPharmatech Co Ltd's Short-Term Investments growth rate?
Short-Term Investments CAGR 5Y
91%

Over the last year, the Short-Term Investments growth was -4%.

Back to Top